Contractor
RADHA PHARMACEUTICALS INC
- UEI
- C1S5SQ88KY67
- Parent UEI
- C1S5SQ88KY67
- Resolved by
- uei
- Confidence
- 1.000
Active from Mar 9, 2026 to Jul 23, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36E79723D0025 EXERCISE OPTION YEAR 3 FOR 36E79723D0025 (ATORVASTATIN CALCIUM TABLETS) WITH NO PRICE CHANGES. | Department of Veterans Affairs | — | Jul 23, 2026 | — |
| 36E79725D0026 EXERCISE OPTION YEAR 1: CARBIDOPA 25MG/LEVODOPA 100MG TAB,SA CARBIDOPA 50MG/LEVODOPA 200MG TAB,SA. 5/23/2026 TO 5/22/2027. | Department of Veterans Affairs | — | Apr 21, 2026 | — |
| 36E79726D0029 NEW AWARD FOR NAPROXEN TABLETS WITH RADHA PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 8/1/2026-7/31/2027. | Department of Veterans Affairs | — | Apr 16, 2026 | — |
| SPE2D226D0010 4610133531! | Department of Defense | — | Mar 19, 2026 | — |
| 36E79723D0004 THIS MODIFICATION IS ISSUED TO EXERCISE THE 3RD OPTION YEAR FOR CLOPIDOGREL BISULFATE TABLETS UNDER CONTRACT 36E79723D0004 WITH RADHA PHARMACEUTICALS INC. FOR THE PERIOD OF 04/15/2026 TO 04/14/2027. | Department of Veterans Affairs | — | Mar 9, 2026 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier C1S5SQ88KY67, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.